Estados financieros detallados de Inspira Technologies OXY B.H.N. Ltd. (IINN): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.7%, margen operativo 25.0%, margen neto -22.1%.
Al precio actual de $1.05, IINN presenta beneficios negativos (P/E no significativo) y un ROE del -5.69%. La capitalización bursátil es de $25M.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | -$4.7M | 0 | 0 | $289000 |
| Coste de Ventas | 0 | $76000 | $203000 | $218000 | $361000 | $406000 | $488000 | $561000 |
| Beneficio Bruto | 0 | -$76000 | -$203000 | -$218000 | -$5.0M | -$406000 | -$488000 | -$272000 |
| I+D | $26400 | $887000 | $3.9M | $3.9M | $8.1M | $7.0M | $6323 | $7.2M |
| Generales y Administrativos | $13200 | $359000 | $2.4M | $9.3M | $6.7M | $4.7M | $4.8M | $5.9M |
| Gastos Operativos | $39600 | $1.3M | $6.3M | $11.9M | $14.6M | $11.7M | -$11267 | $13.3M |
| Beneficio Operativo | -$39600 | -$1.3M | -$6.3M | -$12.2M | $14.9M | -$12.1M | $11267 | -$13.6M |
| EBITDA | 0 | -$4.5M | -$7.0M | -$16.7M | -$14.7M | -$10.9M | -$11096 | -$13.2M |
| Gastos por Intereses | 0 | $9000 | $5000 | $6000 | $181000 | $10000 | 0 | $9000 |
| Beneficio Antes de Impuestos | -$39600 | -$4.6M | -$7.2M | -$17.0M | -$15.0M | -$11.3M | -$11053 | -$13.2M |
| Impuestos | 0 | 0 | 0 | $6000 | -$6.3M | 0 | 0 | 0 |
| Beneficio Neto | -$39600 | -$4.6M | -$7.2M | -$17.0M | -$4.0M | -$11.3M | -$11053 | -$13.2M |
| BPA | $-0.02 | $-0.34 | $-1.01 | $-3.20 | $-1.39 | $-0.93 | $-0.00 | $-0.45 |
| BPA Diluido | $-0.02 | $-0.34 | $-1.01 | $-3.20 | $-1.39 | $-0.93 | $-0.00 | $-0.45 |
| Acciones en Circulación (Diluidas) | $2.0M | $13.5M | $7.2M | $5.3M | $10.8M | $12.1M | $18.5M | $29.6M |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $8000 | $96000 | $496000 | $23.7M | $6.8M | $5.0M | $5.1M | $3.3M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $7.1M | $2.3M | $668000 | 0 |
| Cuentas por Cobrar | 0 | $51000 | $188000 | $210000 | 0 | $432000 | 0 | 0 |
| Inventario | -$3000 | $34949 | 0 | $336000 | -$279000 | 0 | $444000 | $735000 |
| Activos Corrientes | $11000 | $182000 | $684000 | $24.5M | $14.5M | $7.8M | $6.8M | $4.4M |
| Inmovilizado Material | 0 | $192000 | $303000 | $1.4M | $1.5M | $1.5M | $1.3M | $930000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $11000 | $374000 | $987000 | $25.9M | $16.0M | $9.3M | $8.1M | $5.3M |
| Cuentas por Pagar | 0 | $74000 | $3000 | $93000 | $152000 | $198000 | $154000 | $107000 |
| Deuda a Corto | 0 | $4.7M | $399000 | $3.5M | $294000 | $1.8M | $1.9M | $1.4M |
| Pasivos Corrientes | $40000 | $5.0M | $951000 | $4.3M | $1.7M | $3.0M | $3.4M | $2.8M |
| Deuda a Largo | 0 | 0 | $1.6M | $302000 | $398000 | $588000 | 0 | 0 |
| Pasivos Totales | $40000 | $5.0M | $2.7M | $5.5M | $3.2M | $3.6M | $3.7M | $3.0M |
| Reservas | -$33000 | -$4.6M | -$11.8M | -$28.8M | -$44.2M | -$55.5M | -$66.6M | -$79.8M |
| Patrimonio Neto | -$29000 | -$4.6M | -$1.7M | $20.4M | $13.6M | $5.7M | $4.3M | $2.3M |
| Deuda Total | 0 | $4.8M | $2.3M | $1.5M | $1.5M | $878000 | $2.5M | $1.6M |
| Deuda Neta | -$8000 | $4.7M | $1.8M | -$22.3M | -$12.4M | -$6.5M | -$3.3M | -$1.7M |
| Capital Circulante | -$29000 | -$4.8M | -$267000 | $20.2M | $12.8M | $4.8M | $3.4M | $1.6M |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$39600 | -$4.6M | -$7.2M | -$17.0M | -$10.3M | -$11.3M | -$11.1M | -$13.2M |
| Amortizaciones | 0 | $76000 | $203000 | $25000 | $361000 | $111000 | $171000 | $449000 |
| Compensación en Acciones | 0 | $3.3M | $3.9M | $6.7M | $4.9M | $1.5M | $1.9M | 0 |
| Cambio en Capital Circulante | $44400 | $84000 | $348000 | -$233000 | $704000 | $41000 | -$432000 | -$219000 |
| Flujo de Caja Operativo | $4800 | -$1.1M | -$1.9M | -$7.9M | -$7.4M | -$9.8M | -$9.4M | -$9.9M |
| Inversiones (CapEx) | 0 | -$31000 | -$23000 | -$176000 | -$304000 | -$206000 | -$164000 | -$103000 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | $4800 | -$1.1M | -$1.9M | -$8.1M | -$7.7M | -$10.0M | -$9.5M | -$10.0M |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +100.0% | |||||||
| Crecimiento Beneficio Neto (anual) | -11475.8% | -57.8% | -134.5% | +76.4% | -182.0% | +99.9% | -119505.5% | |
| Crecimiento BPA (anual) | -1583.2% | -197.1% | -216.8% | +56.6% | +33.1% | +99.9% | -74900.0% | |
| Cambio en Acciones (anual) | +587.8% | -46.8% | -26.2% | +103.4% | +12.1% | +53.1% | +60.0% | |
| Crecimiento FCF (anual) | -23891.7% | -66.3% | -324.1% | +4.6% | -29.6% | +4.3% | -4.5% | |
| Margen Bruto | 107.7% | -94.1% | ||||||
| Margen Operativo | -318.4% | -4710.7% | ||||||
| Margen EBITDA | 313.9% | -4555.4% | ||||||
| Margen Neto | 85.5% | -4574.4% | ||||||
| Margen FCF | 164.3% | -3447.8% | ||||||
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | 41.9% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $0.00 | $-0.08 | $-0.26 | $-1.52 | $-0.71 | $-0.82 | $-0.52 | $-0.34 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $2.0M | $13.5M | $7.2M | $5.3M | $10.8M | $12.1M | $18.5M | $29.6M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -569.09% |
| Rentabilidad sobre capital invertido | -326.40% |
| Rentabilidad sobre activos | -247.52% |
| Margen bruto | 0.69% |
| Margen operativo | 2503.46% |
| Margen neto | -2213.84% |
Salud financiera
| Deuda / Patrimonio | 0.21 |
| Ratio corriente | 1.56 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -23.62 |
Ratios Clave (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| P/E | -235.15 | -13.97 | -4.70 | -1.30 | -0.93 | -1.14 | -1700.00 | -2.00 |
| P/VC | -321.53 | -13.82 | -20.04 | 1.08 | 1.02 | 2.23 | 4.37 | 11.48 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | -2.98 | 0.00 | 0.00 | 92.25 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 107.7% | 0.0% | 0.0% | -94.1% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | -318.4% | 0.0% | 0.0% | -4710.7% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 85.5% | 0.0% | 0.0% | -4574.4% |
Empresas relacionadas: BFRI · ENSC · FEED · HSCS · ISPC · PTPI · RPID
Explorar sector: Healthcare · Medical - Devices
Más secciones de IINN: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones